Results 71 to 80 of about 2,545,005 (248)
Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial. [PDF]
Aims: To conduct a randomized trial in order to guide the optimum therapy of symptomatic atrioventricular nodal re-entrant tachycardia (AVNRT).
Katritsis, DG +7 more
core +1 more source
ABSTRACT Background Pulsed field ablation (PFA) is an emerging non‐thermal ablation modality with proven safety in atrial arrhythmia ablation. However, data on its performance for ventricular arrhythmias (VA) remain limited. Objective To evaluate the feasibility, safety, and efficacy of PFA for complex VA in a multicenter real‐world US registry ...
Narut Prasitlumkum +22 more
wiley +1 more source
Antiarrhythmic Treatment in Heart Failure
<jats:title>Abstract </jats:title><jats:sec> <jats:title>Purpose of Review</jats:title> <jats:p>Arrhythmias are common in patients with heart failure (HF) and are associated with a ...
Eckardt, Lars +4 more
core +1 more source
Antiarrhythmic drug therapy during cardiopulmonary resuscitation:Should we use it?
Purpose of review The optimal antiarrhythmic drug therapy (amiodarone or lidocaine) in the treatment of ventricular fibrillation/pulseless ventricular tachycardia (VF/pVT) cardiac arrest that is refractory to defibrillation is uncertain.
Jasmeet Soar, Soar, Jasmeet
core +1 more source
Adjunctive ganglionated plexus (GP) ablation did not reduce early AF recurrence after thoracoscopic AF ablation but was associated with a later first recurrence. In the GP‐ablation group, early recurrence was associated with late recurrence; this exploratory finding is compatible with, but does not establish, a greater contribution of pre‐existing ...
Zhenyu Dong +11 more
wiley +1 more source
Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy [PDF]
Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (statins) are the most effective and best-tolerated drugs to treat elevated levels of low-density lipoprotein cholesterol (LDL-C).
Tamargo Menéndez, Juan +5 more
core +1 more source
Prospects for Combination Antiarrhythmic Drug Therapy in Cardiology: Is It Time for a Polypill?
In this article, we discuss the feasibility of combination antiarrhythmic drug therapy in the form of a polypill. In our opinion, this type of treatment is currently limited by various factors discussed in this article. Large-sample studies are needed to
Anatoly O. Rubanenko +2 more
doaj +1 more source
Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow
Atrial fibrillation (AF) is the most common heart rhythm disorder encountered in clinical practice. Each year, the number of patients with AF significantly increases.
V. I. Podzolkov, A. I. Tarzimanova
doaj +1 more source
Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation
Clinical Outcomes of Pulmonary Vein Isolation Alone Versus Additional Lesion Sets in Paroxysmal Atrial Fibrillation ABSTRACT Background Pulmonary vein isolation (PVI) is the standard ablation strategy for paroxysmal atrial fibrillation (PAF). Despite guideline recommendations favoring PVI alone in PAF, some operators routinely perform extra pulmonary ...
Michel Abou Khalil +17 more
wiley +1 more source
Antiarrhythmic activity of amiodarone's desethyl metabolite, which accumulates during oral amiodarone therapy, has been postulated to explain the delayed onset of antiarrhythmic effects during long-term amiodarone therapy.
M Quantz, S Nattel, M Davies
core +1 more source

